Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-020546
Filing Date
2025-06-16
Accepted
2025-06-16 17:47:20
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5148
  Complete submission text file 0001437749-25-020546.txt   6916
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LFB BIOTECHNOLOGIES, S.A.S. 3, AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958
Business Address
Echelard Yann (Reporting) CIK: 0001561958 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 251051250